Reinforce Oral Care With Buccal or Sublingual Buprenorphine
March 2022
A new FDA warning will spur questions about the risk of dental problems with buccal or sublingual buprenorphine (Suboxone, etc).
Labels will now caution about cavities, abscesses, tooth loss, etc. These can happen even in patients withOUT a history of dental problems.
It may be because these products create an acidic environment...which can wear away tooth enamel and lead to decay within weeks or years.
Practical advice for a better career, with unlimited access to CE
Hospital Pharmacy Technician's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote